ROS1 immunohistochemistry among major genotypes of non-small-cell lung cancer

Clinical Lung Cancer

Volumn 16, Issue 2, 2015, Pages 106-111

  Boyle, Theresa A ^a   Masago, Katsuhiro ^b,c   Ellison, Kim E ^a   Yatabe, Yasushi ^c   Hirsch, Fred R ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Adenocarcinoma; Biomarker; Gene rearrangement; NSCLC; ROS1

Indexed keywords

ONCOPROTEIN; PROTEIN TYROSINE KINASE; ROS1 PROTEIN, HUMAN;

ADENOCARCINOMA; COMPARATIVE STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; GENETICS; GENOTYPE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; NON SMALL CELL LUNG CANCER; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; GENE REARRANGEMENT; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 84922975873     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2014.10.003     Document Type: Article

References (27)

1. C. Birchmeier, S. Sharma, and M. Wigler Expression and rearrangement of the ROS1 gene in human glioblastoma cells Proc Natl Acad Sci U S A 84 1987 9270 9274
2. T.L. Gu, X. Deng, and F. Huang Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma PLoS One 6 2011 e15640
3. K. Rikova, A. Guo, and Q. Zeng Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer Cell 131 2007 1190 1203
4. J. Lee, S.E. Lee, and S.Y. Kang Identification of ROS1 rearrangement in gastric adenocarcinoma Cancer 119 2013 1627 1635
5. D.L. Aisner, T.T. Nguyen, and D.D. Paskulin ROS1 and ALK Fusions in colorectal cancer, with evidence of intra-tumoral heterogeneity for molecular drivers Mol Cancer Res 12 2014 111 118
6. A.H. Birch, S.L. Arcand, and K.K. Oros Chromosome 3 anomalies investigated by genome wide SNP analysis of benign, low malignant potential and low grade ovarian serous tumours PLoS One 6 2011 e28250
7. C.P. Giacomini, S. Sun, and S. Varma Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types PLoS Genetics 9 2013 e1003464
8. K. Takeuchi, M. Soda, and Y. Togashi RET, ROS1 and ALK fusions in lung cancer Nat Med 18 2012 378 381
9. K.D. Davies, and R.C. Doebele Molecular pathways: ROS1 fusion proteins in cancer Clin Cancer Res 19 2013 4040 4045
10. K. Bergethon, A.T. Shaw, and S.H. Ou ROS1 rearrangements define a unique molecular class of lung cancers J Clin Oncol 30 2012 863 870
11. S.H. Ou, C.H. Bartlett, M. Mino-Kenudson, J. Cui, and A.J. Iafrate Crizotinib for the treatment of ALK-rearranged non-small cell lung cancer: a success story to usher in the second decade of molecular targeted therapy in oncology Oncologist 17 2012 1351 1375
12. Shaw AT, Ou SH, Bang YJ, et al. Crizotinib in ROS1-rearranged non-small-cell lung cancer. N Engl J Med Epub 2014 Sep 27.
13. K.D. Davies, A.T. Le, and M.F. Theodoro Identifying and targeting ROS1 gene fusions in non-small cell lung cancer Clin Cancer Res 18 2012 4570 4579
14. H.R. Kim, S.M. Lim, and H.J. Kim The frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinoma Ann Oncol 24 2013 2364 2370
15. Y.F. Chen, M.S. Hsieh, and S.G. Wu Clinical and the prognostic characteristics of lung adenocarcinoma patients with ROS1 fusion in comparison with other driver mutations in East Asian populations J Thorac Oncol 9 2014 1171 1179
16. L. Mescam-Mancini, S. Lantuejoul, and D. Moro-Sibilot On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas Lung Cancer 83 2014 168 173
17. P.A. Bunn Jr., F.R. Hirsch, and D.L. Aisner Is there clinical value to prognostic signatures in early stage NSCLC? Clin Cancer Res 20 2014 1727 1729
18. V.M. Rimkunas, K.E. Crosby, and D. Li Analysis of receptor tyrosine kinase ROS1-positive tumors in non-small cell lung cancer: identification of a FIG-ROS1 fusion Clin Cancer Res 18 2012 4449 4457
19. L.M. Sholl, H. Sun, and M. Butaney ROS1 immunohistochemistry for detection of ROS1-rearranged lung adenocarcinomas Am J Surg Pathol 37 2013 1441 1449
20. H.J. Lee, H.S. Seol, and J.Y. Kim ROS1 receptor tyrosine kinase, a druggable target, is frequently overexpressed in non-small cell lung carcinomas via genetic and epigenetic mechanisms Ann Surg Oncol 20 2013 200 208
21. A. Warth, T. Muley, and H. Dienemann ROS1 expression and translocations in non-small cell lung cancer: clinicopathological analysis of 1478 cases Histopathology 65 2014 187 194
22. Y. Yatabe, T. Hida, Y. Horio, T. Kosaka, T. Takahashi, and T. Mitsudomi A rapid, sensitive assay to detect EGFR mutation in small biopsy specimens from lung cancer J Mol Diagn 8 2006 335 341
23. K. Tomizawa, K. Suda, and R. Onozato Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers Lung Cancer 74 2011 139 144
24. K. Takeuchi, Y.L. Choi, and M. Soda Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts Clin Cancer Res 14 2008 6618 6624
25. T. Kohno, H. Ichikawa, and Y. Totoki KIF5B-RET fusions in lung adenocarcinoma Nat Med 18 2012 375 377
26. A. Yoshida, K. Tsuta, and S. Wakai Immunohistochemical detection of ROS1 is useful for identifying ROS1 rearrangements in lung cancers Mod Pathol 27 2014 711 720
27. Y.J. Cha, J.S. Lee, and H.R. Kim Screening of ROS1 rearrangements in lung adenocarcinoma by immunohistochemistry and comparison with ALK rearrangements PLoS One 9 2014 e103333